Walsham, James http://orcid.org/0000-0001-6852-4378
Hammond, Naomi http://orcid.org/0000-0002-6559-7747
Blumenthal, Antje http://orcid.org/0000-0003-3673-7015
Cohen, Jeremy http://orcid.org/0000-0002-1356-8506
Myburgh, John http://orcid.org/0000-0003-4088-7016
Finfer, Simon http://orcid.org/0000-0002-2785-5864
Evans, David http://orcid.org/0000-0003-0663-4621
Peake, Sandra http://orcid.org/0000-0001-6682-7973
Kruger, Peter http://orcid.org/0000-0002-3216-2958
McCullough, James http://orcid.org/0000-0002-7292-2237
Johnk, Loki http://orcid.org/0000-0001-8698-9697
Ghelani, Dhaval http://orcid.org/0009-0009-7150-0583
Billot, Laurent http://orcid.org/0000-0002-4975-9793
Shan, Sana http://orcid.org/0000-0001-5416-6055
Meyer, Jason http://orcid.org/0000-0002-9344-1280
Rajbhandari, Dorrilyn http://orcid.org/0000-0001-8883-0428
Koch, Carolyn http://orcid.org/0000-0001-7260-8099
Bellomo, Rinaldo http://orcid.org/0000-0002-1650-8939
Burrell, Louise M. http://orcid.org/0000-0003-1863-7539
Young, Morag http://orcid.org/0000-0003-0450-5375
Roberts, Michael http://orcid.org/0000-0003-3894-5301
Mackenzie, Lorraine http://orcid.org/0000-0002-6990-6324
Medley, Gregory http://orcid.org/0000-0002-7462-9536
Dalton, Joshua http://orcid.org/0000-0002-9365-7903
Venkatesh, Balasubramanian http://orcid.org/0000-0002-3234-5244
Funding for this research was provided by:
National Health and Medical Research Council (1162182)
University of New South Wales
Article History
Received: 15 May 2024
Accepted: 16 August 2024
First Online: 5 September 2024
Declarations
:
: BV, JM, NH and SF are supported by a Leadership Fellowship and AB from an Ideas Grant from the National Health and Medical Research Council of Australia. BV and NH receive institutional research support from Baxter for the conduct of a clinical trial in patients with diabetic ketoacidosis. AB is supported by an Australian Research Council Future Fellowship and grants from the Translational Research Institute, Australian Infectious diseases Research Centre and Metro South health. JD, MR and LM are supported by a grant from the Hospital Research Foundation. MY is supported by a grant from the Baker Foundation and the Australian Research Council. SF has received consulting fees from RevImmune Inc and is Director of Sepsis Australia (honorary) and Asia Pacific Sepsis Alliance (honorary). All other others do not report any conflict of interest.